Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.

The biological roles of estrogen receptor 1 (ERS1), estrogen receptor 2 (ERS2), and aromatase (CYP19A1) genes in the development of non-small cell lung cancer (NSCLC) is unclear, as is the use of their expression as a prognostic factor. The aim of this study was to investigate the prognostic value o...

Full description

Bibliographic Details
Main Authors: Unai Aresti, Sergio Carrera, Eluska Iruarrizaga, Natalia Fuente, Ines Marrodan, Abigail Ruiz de Lobera, Alberto Muñoz, Aitziber Buque, Elizabeth Condori, Irene Ugalde, Begoña Calvo, Guillermo López Vivanco
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4195686?pdf=render
id doaj-a3fb01baee1c46c881deeae40f154586
record_format Article
spelling doaj-a3fb01baee1c46c881deeae40f1545862020-11-24T21:38:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10965910.1371/journal.pone.0109659Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.Unai ArestiSergio CarreraEluska IruarrizagaNatalia FuenteInes MarrodanAbigail Ruiz de LoberaAlberto MuñozAitziber BuqueElizabeth CondoriIrene UgaldeBegoña CalvoGuillermo López VivancoThe biological roles of estrogen receptor 1 (ERS1), estrogen receptor 2 (ERS2), and aromatase (CYP19A1) genes in the development of non-small cell lung cancer (NSCLC) is unclear, as is the use of their expression as a prognostic factor. The aim of this study was to investigate the prognostic value of estrogen receptors and aromatase mRNA expression, along with aromatase protein concentration, in resected NSCLC patients. Tumor and non-tumor lung tissue samples were analyzed for the mRNA expression of ERS1, ERS2 and CYP19A1 by RT-PCR. Aromatase concentration was measured with an ELISA. A total of 96 patients were included. ERS1 expression was significantly higher in non-tumor tissue than in tumor samples. Two gene expression categories were created for each gene (and protein): high and low. ERS1 high category showed increased overall survival (OS) when compared to the low expression category. Aromatase protein concentration was significantly higher in tumor samples. Higher ERS1 expression in tumor tissues was related to longer overall survival. The analysis of gene expression combinations provides evidence for longer OS when both ERS1 and ERS2 are highly expressed. ESR1, alone or in combination with ERS2 or CYP19A1, is the most determining prognostic factor within the analyzed 3 genes. It seems that ERS1 can play a role in NSCLC prognosis, alone or in combination with other genes such as ERS2 or Cyp19a1. ERS2 in combination with aromatase concentration could have a similar function.http://europepmc.org/articles/PMC4195686?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Unai Aresti
Sergio Carrera
Eluska Iruarrizaga
Natalia Fuente
Ines Marrodan
Abigail Ruiz de Lobera
Alberto Muñoz
Aitziber Buque
Elizabeth Condori
Irene Ugalde
Begoña Calvo
Guillermo López Vivanco
spellingShingle Unai Aresti
Sergio Carrera
Eluska Iruarrizaga
Natalia Fuente
Ines Marrodan
Abigail Ruiz de Lobera
Alberto Muñoz
Aitziber Buque
Elizabeth Condori
Irene Ugalde
Begoña Calvo
Guillermo López Vivanco
Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.
PLoS ONE
author_facet Unai Aresti
Sergio Carrera
Eluska Iruarrizaga
Natalia Fuente
Ines Marrodan
Abigail Ruiz de Lobera
Alberto Muñoz
Aitziber Buque
Elizabeth Condori
Irene Ugalde
Begoña Calvo
Guillermo López Vivanco
author_sort Unai Aresti
title Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.
title_short Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.
title_full Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.
title_fullStr Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.
title_full_unstemmed Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.
title_sort estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description The biological roles of estrogen receptor 1 (ERS1), estrogen receptor 2 (ERS2), and aromatase (CYP19A1) genes in the development of non-small cell lung cancer (NSCLC) is unclear, as is the use of their expression as a prognostic factor. The aim of this study was to investigate the prognostic value of estrogen receptors and aromatase mRNA expression, along with aromatase protein concentration, in resected NSCLC patients. Tumor and non-tumor lung tissue samples were analyzed for the mRNA expression of ERS1, ERS2 and CYP19A1 by RT-PCR. Aromatase concentration was measured with an ELISA. A total of 96 patients were included. ERS1 expression was significantly higher in non-tumor tissue than in tumor samples. Two gene expression categories were created for each gene (and protein): high and low. ERS1 high category showed increased overall survival (OS) when compared to the low expression category. Aromatase protein concentration was significantly higher in tumor samples. Higher ERS1 expression in tumor tissues was related to longer overall survival. The analysis of gene expression combinations provides evidence for longer OS when both ERS1 and ERS2 are highly expressed. ESR1, alone or in combination with ERS2 or CYP19A1, is the most determining prognostic factor within the analyzed 3 genes. It seems that ERS1 can play a role in NSCLC prognosis, alone or in combination with other genes such as ERS2 or Cyp19a1. ERS2 in combination with aromatase concentration could have a similar function.
url http://europepmc.org/articles/PMC4195686?pdf=render
work_keys_str_mv AT unaiaresti estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT sergiocarrera estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT eluskairuarrizaga estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT nataliafuente estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT inesmarrodan estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT abigailruizdelobera estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT albertomunoz estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT aitziberbuque estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT elizabethcondori estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT ireneugalde estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT begonacalvo estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
AT guillermolopezvivanco estrogenreceptor1geneexpressionanditscombinationwithestrogenreceptor2oraromataseexpressionpredictssurvivalinnonsmallcelllungcancer
_version_ 1725934628679712768